IL10 and graft versus host disease: When the early and late activation markers were analyzed in human T cells present in the spleen of these mice, WT-MSCs and more markedly CXCR4-IL10-MSCs increased the proportion of CD4+CD25+T cells, compared with the control GvHD group (Figure S3A, 2B).